Evidence map›Paper›PMID 35233035›Full record

Trial reportScientific reports2022

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study.

Alexandre Pérez-González, Alejandro Araújo-Ameijeiras, Alberto Fernández-Villar, Manuel Crespo, Eva Poveda, Cohort COVID-19 of the Galicia Sur Health Research Institute

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 90 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 8 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 8 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Post-COVID-19 physical and mental quality of life: a latent profile analysis and predictive factors.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Alexandre Pérez-GonzálezGroup of Virology and Pathogenesis, Internal Medicine Department, Álvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor Nº 341, 36312, Vigo, Spain. alexandre.perez@iisgaliciasur.es.
Alejandro Araújo-AmeijeirasGroup of Virology and Pathogenesis, Internal Medicine Department, Álvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor Nº 341, 36312, Vigo, Spain.
Alberto Fernández-VillarPneumology Service, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.
Manuel CrespoInfectious Diseases Department, Hospital Universitari de Bellvitge, IDIBEL, Barcelona, Spain.
Eva PovedaGroup of Virology and Pathogenesis, Internal Medicine Department, Álvaro Cunqueiro Hospital, Galicia Sur Health Research Institute (IIS Galicia Sur), Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo. St. Clara Campoamor Nº 341, 36312, Vigo, Spain.
Cohort COVID-19 of the Galicia Sur Health Research Institute
Galicia Sur Biomedical Foundation · ESUniversity Hospital Complex Of Vigo · ESBellvitge University Hospital · ESComplexo Hospitalario Universitario A Coruña · ESServicio Gallego de Salud · ES

Funding

Instituto de Salud Carlos III CM20/00243Instituto de Salud Carlos III COV20/00698
6 · The paper itself

Abstract

Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of this study is to describe persisting symptoms 6 months after COVID-19 diagnosis in a prospective cohort in the Northwest Spain. This is a prospective cohort study performed in the COHVID-GS. This cohort includes patients in clinical follow-up in a health area of 569,534 inhabitants after SARS-CoV-2/COVID-19 diagnosis. Clinical and epidemiological characteristics were collected during the follow up. A total of 248 patients completed 6 months follow-up, 176 (69.4%) required hospitalization and 29 (10.2%) of them needed critical care. At 6 months, 119 (48.0%) patients described one or more persisting symptoms. The most prevalent were: extra-thoracic symptoms (39.1%), chest symptoms (27%), dyspnoea (20.6%), and fatigue (16.1%). These symptoms were more common in hospitalized patients (52.3% vs. 38.2%) and in women (59.0% vs. 40.5%). The multivariate analysis identified COPD, women gender and tobacco consumption as risk factors for long COVID. Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients (52.3% vs. 38.2%). Based on these findings, special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and women.

Indexed as

COVID-19HospitalizationSARS-CoV-2AdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk FactorsSex FactorsSpain

Identifiers

PMID35233035
PMCPMC8888560
OpenAlexW4220816323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.